INTRODUCTION
The rising rates of systemic fungal infections worldwide have stimulated interest in developing vaccines (Cutler et al., 2007) . Although experimental vaccines are under study, none are commercially available (Cutler et al., 2007) . An understanding of the mode of action of fungal vaccines will enhance their application in human populations. Th1-cell responses mediated by IL-12 and IFN-g are believed to foster protective immunity to many pathogenic fungi (Wü thrich et al., 2012) . During the earliest stages of fungal infection, pattern recognition receptors on myeloid lineage cells sense fungal pathogens and surfaces (Brown, 2011) . Myeloid cells, particularly dendritic cells (DCs), bridge innate and adaptive immunity to pathogens. DCs have thus become a target for vaccine development strategies (Steinman, 2008) .
The lung airways of all species are lined with an intraepithelial dendritic network of MHCII hi CD11c hi cells that are mostly CD11b
À (Lambrecht and Hammad, 2009 DCs, which are enriched in CD103 + subsets. Alveolar macrophages also express CD11c (not CD11b), confusing the analysis of lung DCs unless autofluorescence is used for identifying macrophages (Vermaelen and Pauwels, 2004) . Under inflammatory conditions, such as microbial challenge, CD11b + monocytederived DCs that rapidly upregulate CD11c and retain Ly6C as a remnant of monocytic descent are recruited (Shi and Pamer, 2011) . Monocyte-derived DCs are important for priming T cell responses to microbes (Hohl et al., 2009; Serbina et al., 2008) . These DCs prime Th1 cell responses and IFN-g-producing Agspecific CD4 + transgenic (tg) T cells in pulmonary aspergillosis (Hohl et al., 2009) . In Aspergillus infection, CCR2 + Ly6C hi DCs are required to prime T cells in the lung, yet not in the spleen. We recently analyzed sequential stages during the induction of vaccine immunity to fungi after subcutaneous (s.c.) injection (Ersland et al., 2010) . Monocyte-derived DCs initially take up the most vaccine yeast and traffic them to the skin-draining LNs. However, the direct priming of naive Ag-specific CD4 T cells in vivo is governed by LN-resident DCs and skin-derived DCs. In fact, other skin DCs compensate for monocyte-derived DCs in Ccr2 À/À mice lacking the cells.
Vaccinologists strive to harness protective immunity at mucosal sites of initial pathogen entry. We sought to immunize against fungal respiratory pathogens by delivering vaccines into the respiratory tract. Although delivery of an attenuated strain of Blastomyces dermatitidis (Bd) into the skin protects 100% of mice against a lethal pulmonary challenge, and most develop sterilizing immunity (Wü thrich et al., 2000) , vaccine delivery intranasally (i.n.) failed to protect and 100% of vaccinees succumbed to infection. Herein, we studied the mechanism behind the failure in priming antifungal vaccine immunity at the respiratory mucosa.
We report that fungi subvert the induction of vaccine immunity at the respiratory mucosa by inducing lung matrix metalloproteinase 2 (MMP2), which suppresses the action of CCL7 and impairs recruitment and maturation of Ly6C hi inflammatory monocyte-derived DCs in the lung. Elimination of mature Ly6 hi DCs at this site retarded the activation, expansion, and differentiation of IFN-g + CD4 + T cells. Conversely, administering an MMP2 inhibitor or CCL7 during vaccine delivery restored recruitment of Ly6C hi monocytes to the lung and priming of CD4 + T cells. Our results pinpoint mechanisms that underpin vaccination against fungi at the respiratory mucosa. They also highlight host and microbial strategies that must be overcome to engineer fungal and other vaccines that induce respiratory mucosal immunity. Mucosal vaccination against respiratory agents may require manipulation of host MMPs that alter chemokine signals needed to recruit Ly6C hi inflammatory monocytes and prime CD4 + T cells at the respiratory mucosa.
RESULTS

Fungal Vaccination at the Respiratory Mucosa
Subcutaneous injection of mice with a live attenuated Bd strain engenders 100% survival against a lethal pulmonary challenge (Wü thrich et al., 2000) , but inconsistent sterilizing immunity. Because the natural route of infection is inhalation of spores, we sought to enhance the vaccine's efficacy by delivering it into the respiratory tract. All mice vaccinated intranasal (i.n.) (Wü thrich et al., 2000) or intratracheally (i.t.) (data not shown) were unable to control infection and died after pulmonary challenge. This scenario contrasts with that for Histoplasma capsulatum (Hc), in which primary pulmonary infection induces protective immunity and resistance against lethal pulmonary challenge (Deepe and Seder, 1998) . Because these two fungal infections require cellular immunity for resistance, we compared the priming of CD4 + T cells for each of them to uncover the reasons for failure versus success in priming of T cells at the respiratory mucosa. Th1 cell differentiation occurs fully after CD4 + T cells migrate to the lung (Rivera et al., 2006) . Although i.t. vaccination with Bd induced activated CD4 + T cells (CD44 + ) cells in the lung, Th1 cells failed to accrue and <1% produced IFN-g ( Figure 1A ). There were z1,000-fold less IFN-g + CD4 T cells in the lung after i. Figure 2B ). By staining yeast with PKH26, we honed in on lung APC that harbored yeast ( Figures 2C, 2D , and S2D-S2F). CD103
+ DCs contained few yeast ( Figure 3C ). Figure 2G ). Still, the biggest difference between the two fungi was again in Ly6C hi CD11b + cells; the proportion of these cells harboring Hc (7.2%) was z12-fold higher than that for Bd (0.59%) ( Figure 2G ). Consequently, in the MLN, there were >1000-fold more Ly6C hi inflammatory monocytes with Hc (R10 3 cells) than Bd (%10 cells) ( Figure 2H Figure 3A ). In the mixed infection, the distribution and numbers of DCs showed a paucity of Ly6C hi CD11b + DCs (0.26%) that was similar to mice vaccinated with Bd (0.19%) and much lower than mice that received Hc (13.7%) ( Figure 3A) ; the numbers of total Ly6C
hi DCs in the lung followed similar trends with almost identical patterns for Bd and mixed infections, each much lower than for Hc vaccination ( Figure 3B ). To see whether mixed infection perturbed the numbers of APC harboring yeast, we stained the yeast with PKH26. The total number of yeast-loaded APCs in the lung was increased in the mixed infection ( Figure S3B Bd-alone groups, as compared to the H. capasulatum group ( Figure 3B ). The patterns in the MLN mirrored those in the lung ( Figures 3C and 3D ). Thus, Bd interferes with either recruitment or entry and migration of Ly6C hi monocytes in the lung and MLN and can do so even in the case of a strong inducing stimulus like respiratory exposure to Hc. Ly6C hi monocytes that enter the lung in response to infection mature upon transition to DCs, involving downregulation of Ly6C and upregulation of CD11c and MHC class II (Osterholzer et al., 2009) . We explored this process in the three groups: either yeast alone or mixed together. For Ly6C hi monocytes that entered the lung in response to mucosal vaccination with Bd, both the Ly6C expression and the CD11c expression were much lower than that compared to the Hc group, and the mixed infection yielded a pattern similar to that for Bd alone ( Figure 3E ). Thus, in the setting of Bd vaccine, low Ly6C expression was not due to the maturation to CD11c + DCs; the yeast instead blunted the maturation of CD11cDCs. Ly6C hi inflammatory monocytes trafficking to organs may require CCR2 expression . Over 90% of the Ly6C hi monocytes that migrate into the MLNs in response to Hc display CCR2 ( Figure 3F ). Among the CD11c + Ly6C + cell population in the MLN in this setting, 90% express CCR2. Importantly, Ly6C hi CD11c + CCR2 + cells numbered z5-fold more after the mucosal delivery of Hc, compared to Bd or mixed infection ( Figure 3G ). Figure 4A ). This increase could be due to trapping of cells in the marrow or increased production. To distinguish these possibilities, we studied Ccr2 À/À mice in which these cells cannot exit the marrow (Serbina and Pamer, 2006) . Production is increased in the Hc group relative to the other groups ( Figure S4A ), suggesting that overproduction does not explain the accumulation for Bd relative to Hc in wild-type mice. We did not see a difference between groups in the number of circulating monocytes during 2-5 days after vaccination (data not shown). Thus, mucosal delivery of Bd leads to failure of egress and trapping of Ly6C hi monocytes in the marrow rather than defective monocyte extravasation into the lung. The major signals that induce egress of CCR2 + monocytes from the bone marrow are CCL2 and CCL7 Tsou et al., 2007) . To see whether Bd affected these chemokines, we analyzed levels in the lungs and serum of mice from the three groups. The most striking difference was elevated serum levels of CCL7 in those that received Bd i.t. (Figure 4B ). We tested the activity of these sera in promoting migration of Ly6C hi monocytes in vitro. Sera from mice that got Hc promoted the migration of Ly6C hi monocytes, whereas sera from the Bd group did not ( Figure 4C) . Thus, the elevated levels of CCL7 in Bd sera failed to induce chemotaxis.
Mucosal Vaccination with
Chemokines can be inactivated by serine proteases of mammalian or microbial origin. To test whether inactive CCL7 might explain the defects in bone marrow egress of Bd-vaccinated mice, we vaccinated the mice together with recombinant CCL7. Recombinant CCL7 given to Bd-vaccinated mice enhanced the egress of Ly6C hi monocytes out of the marrow and induced their recruitment into the lungs ( Figure 4D ). Thus, the elevated endogenous levels of CCL7 in serum were not functional in vivo.
Inactive chemokines can desensitize their receptor (Ali et al., 2005) . We studied the migration of bone marrow monocytes in vitro in response to both CCL7 and CCL2. Ly6C hi monocytes from naive mice showed a z3-fold increase in migration toward these chemokines compared to medium alone, whereas cells from Bd-vaccinated mice showed significantly less migration toward the ligands ( Figure S4B ). We further analyzed receptor desensitization by measuring Ca 2+ flux. The flux of bone marrow Ly6C hi monocytes in response to CCL7 as well as CCL2 is curtailed in cells from Bd-vaccinated mice compared to naive mice ( Figure 4E ; data not shown). Thus, Ly6C hi monocytes from Bd-vaccinated mice showed reduced sensitivity to their ligands, promoting their trapping in the marrow and poor recruitment to the lung.
Mammalian Lung MMP2 Is Induced by Fungal Vaccination at the Respiratory Mucosa
Chemokines can be inactivated by mammalian MMPs. The gelatinase MMP2 acts on CCL7 converting it into an inactive or antagonistic form (McQuibban et al., 2000; McQuibban et al., 2002) . We investigated lung MMP2 in response to vaccination at the respiratory mucosa. The level of active MMP2 in bronchoalveolar lavage (BAL) fluid was several-fold higher in mice vaccinated with Bd versus Hc ( Figure 5A ). To see whether the MMP2 levels affected chemokine-mediated egress of Ly6C hi monocytes from the marrow to the lung, we inhibited MMPs during vaccine administration. The broad MMP inhibitor, GM6001, and the MMP2-selective inhibitor promoted egress of Ly6C hi monocytes from the bone marrow ( Figure S5A ) and increased their recruitment to the lung in mice vaccinated i.t. with Bd ( Figure 5B ). These inhibitors did not affect the growth of the fungus in the lung (data not shown). Vaccination of Mmp2 À/À mice also augmented the release of Ly6C hi monocytes from the marrow ( Figure S5B ) and influx of these cells into the lung compared to vaccinated wild-type mice ( Figure 5C ). Thus, induction of lung MMP2 and inactive CCL7 underpin the trapping of Ly6C hi monocytes in the bone marrow and their failure to traffic to the lung in response to fungal vaccine administration at the respiratory mucosa. Figures   6C and 6D) , and especially after these T cells exited the nodes and migrated back into the lung ( Figures 6F and 6G ). In addition to impairing the differentiation of 1807 into Th1 cells, the loss of CCR2 changed the ratio of cytokine producing 1807 cells in favor of T13 and T17 cells in response to Hc ( Figure 6G) ( Figure S6C ). We verified that congenic transferred DCs persisted in the lungs over several days ( Figure S6D ). We analyzed the priming and differentiation of separately transferred Bd 1807 cells (and endogenous CD4 + T cells) in lungs 9 days after DC transfer.
In Ccr2 À/À mice, transfer of Ly6C hi monocytes enhanced the number of IFN-g + 1807 cells after mucosal vaccination ( Figures   7A-7C ): they rose z100-fold in mice that received Bd (note Bd only versus Bd + DCs in Figure 7B ) and z10-fold in mice that received Hc (note Hc only versus Hc + DCs Figure 7E ; note Bd only versus Bd + DCs), and the percentage of these cells by nearly 10-fold ( Figure 7D ; note Bd only versus Bd + DCs). Comparable trends were observed in the endogenous CD4 + T cell pool ( Figures 7D and   7F ). Thus, impaired recruitment and maturation of Ly6C hi monocytes led to failed priming of CD4 T cells and skewing of their differentiation away from Th1 cells upon mucosal vaccination with Bd. These events were remediated by the adoptive transfer of Ly6C hi monocytes.
DISCUSSION
CD4
+ T cells that produce IFN-g are pivotal in immunity to fungi (Cutler et al., 2007) . Here, we found that respiratory mucosal vaccination with Bd did not prime IFN-g-producing endogenous CD4 + T cells. We used a TCR tg mouse to track Ag-specific T cells to decipher the mechanism. The host response to attenuated fungus, involving exuberant MMP and restrained inflammation, paradoxically undermined downstream priming of T cells. This finding offers a cautionary note to vaccinologists harnessing vaccine immunity at the respiratory mucosa.
Subcutaneous delivery of attenuated Bd recruits Ly6C hi DCs to the injection site, which ferry yeast into the sdLNs (Ersland et al., 2010 and succumb to infection due to overproduction of IL-4 and alternative activation of pulmonary macrophages (Szymczak and Deepe, 2009 ). Several chemokines can bind CCR2. CCL2 and CCL7 are the main CCR2 ligands in inflammatory settings Tsou et al., 2007) and help mobilize monocytes from the bone marrow. Vaccination with Bd led to trapping of these cells in the marrow and was also associated with high levels of CCL7 in serum. The serum CCL7 in these mice was inactive, failing to promote CCR2-dependent migration of Ly6c hi monocytes in chemotactic assays. Further, treatment of these vaccinated mice with rCCL7 repaired the deficit, promoting egress of CCR2 + cells from the marrow and entry into the lung. We propose that CCL7 was rendered inactive by MMP2 because this product was elevated in Bd-vaccinated mice and its inhibition relieved marrow trapping and promoted Ly6C hi cell recruitment to the lung. Removal of N-terminus residues of CCL7 by MMP2 impairs its activity, yet CCL7 can still bind its receptor and compete with CCL2 reduced monocyte recruitment to inflamed LNs and diminished production of IL-12 at the time of CD4 + T cell priming (Nakano et al., 2009; Peters et al., 2000; Peters et al., 2001) . Similarly, in pulmonary cryptococcosis, Ccr2 À/À mice redirect CD4 + T cell differentiation from Th1 to Th2 cells (Blease et al., 2000; Traynor et al., 2000) .
Impaired recruitment and maturation of Ly6C hi monocytes skewed the differentiation of Bd 1807 cells toward IL-13-and IL-17-producing cells. This was especially evident in the 1807 cells that had fully differentiated after migrating back to the lung in Ccr2 À/À mice that received Hc. This was also true for 1807 cells in mice that received mixed infection. Our findings suggest that other APCs in the lung of wild-type mice that received Bd or mixed infection or in the Ccr2 À/À mice that received Hc, promote the differentiation of CD4 + T cells into IL-13-and IL-17-producing cells. Szymczak and Deepe (2009) found that lung IFN-g levels were unaltered in Hc infected Ccr2 À/À mice, but elevated IL-4 levels instead led to their death. IL-17 levels were not reported in that study, but it was not possible to track Ag-specific T cells to assess skewed differentiation in the LNs or lung. Priming Ag-specific immunity at mucosal sites of pathogen entry is an active area in vaccine development. Our study highlights pitfalls in applying this strategy broadly across pathogen kingdoms. There are four commercially available mucosal vaccines: polio, rotavirus, Salmonella typhi, and influenzaeach a live, attenuated vaccine. HIV vaccine development is focused on strategies for a mucosal vaccine. Intranasal vaccine delivery of respiratory viruses is thought to prime immunity in nasal mucosa-associated lymphoreticular tissue, and engage not only s-IGA, but also T cell immunity, particularly CTLs. Persistent antigen in the lung after influenza A infection fosters antigen uptake by specialized respiratory DC that prime memory T cells (Kim et al., 2010) . Although CCR2 + cells govern resistance to M. tuberculosis (Peters et al., 2001) , enhanced recruitment of inflammatory monocytes to the lungs of mice infected with M. tuberculosis with intranasal poly-IC unexpectedly enhanced pathogen growth in this permissive population and lung tissue injury despite unaltered production of IFN-g (Antonelli et al., 2010) .
These studies illustrate differences among pathogen kingdoms in vaccine or therapeutic strategies targeted to respiratory sites of pathogen entry. Our work sheds new light on this variability by highlighting the role of chemokines and their cellular targets in inducing mucosal immunity and by unveiling the paradoxical effect of the host in undermining immunity to a mucosal vaccine. To optimize the efficacy of mucosal vaccination, suitable vaccine adjuvants may thus need to target host MMP responses that counter adaptive immunity at the lung mucosa.
Targeted recruitment of leukocytes to the lung on vaccination may augment vaccine strategies.
EXPERIMENTAL PROCEDURES Fungi
Bd strain 55, Hc strain G217B and C. albicans strain SC5314 were previously described (Brandhorst et al., 1999) . For a detailed description, see Supplemental Experimental Procedures.
Mice
The generation and characterization of Bd 1807 mice is described in detail in the accompanying Supplemental Experimental Procedures.
Desensitization Studies
For measuring monocyte migration in response to serum or chemokine, bone marrow cells were enriched for Ly6C 
